Characterization of Pellino2, a substrate of IRAK1 and IRAK4

被引:46
|
作者
Strelow, A [1 ]
Kollewe, C [1 ]
Wesche, H [1 ]
机构
[1] Tularik Inc, San Francisco, CA 94080 USA
关键词
IL-1; signalling; IRAK; Pellino;
D O I
10.1016/S0014-5793(03)00697-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-1 (IL-1) receptor-associated kinases (IRAKs) are central components of Toll/IL-1 receptor (TIR) signaling pathways. In an attempt to discover novel signal transducers in TIR signaling, we identified human Pellino2 as an interaction partner of IRAK4. Pellino2 interacts with kinase-active as well as kinase-inactive IRAK1 and IRAK4. Furthermore, Pellino2 is one of the first substrates identified for IRAK1 and IRAK4. Functional studies using overexpression or RNAi knock-down of Pellino2 suggest a role of Pellino2 as a scaffolding protein similar to Pellino1. However, unlike Pellino1, Pellino2 does not seem to activate a specific transcription factor, but links TIR signaling to basic cellular processes. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:157 / 161
页数:5
相关论文
共 50 条
  • [41] IRAK4 degrader to take on innate immunity
    Asher Mullard
    Nature Biotechnology, 2020, 38 : 1221 - 1223
  • [42] Suppression of IRAK1 or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding-Defective Mutant of ABIN1
    Nanda, Sambit K.
    Lopez-Pelaez, Marta
    Arthur, J. Simon C.
    Marchesi, Francesco
    Cohen, Philip
    JOURNAL OF IMMUNOLOGY, 2016, 197 (11): : 4266 - 4273
  • [43] Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling
    Su-Chang Lin
    Yu-Chih Lo
    Hao Wu
    Nature, 2010, 465 : 885 - 890
  • [44] IRAK1 Gene Polymorphism in Rheumatoid Arthritis
    Hosseini, Najme
    Tahoori, Mohammad Taher
    Mohammadzadeh, Adel
    Jaliani, Hossein Zarei
    Sani, Morteza Bitaraf
    Salehabadi, Hosein Soleimani
    IMMUNOLOGICAL INVESTIGATIONS, 2021, 50 (2-3) : 304 - 321
  • [45] Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2
    Kawagoe, Tatsukata
    Sato, Shintaro
    Matsushita, Kazufumi
    Kato, Hiroki
    Matsui, Kosuke
    Kumagai, Yutaro
    Saitoh, Tatsuya
    Kawai, Taro
    Takeuchi, Osamu
    Akira, Shizuo
    NATURE IMMUNOLOGY, 2008, 9 (06) : 684 - 691
  • [46] OxLDL inhibits LPS-induced IFNβ expression by Pellino3-and IRAK1/4-dependent modification of TANK
    Tzieply, Nico
    Kuhn, Anne-Marie
    Morbitzer, Daniel
    Namgaladze, Dmitry
    Heeg, Annika
    Schaefer, Liliana
    von Knethen, Andreas
    Jensen, Liselotte E.
    Bruene, Bernhard
    CELLULAR SIGNALLING, 2012, 24 (06) : 1141 - 1149
  • [47] 茶多酚联合CO2激光治疗尖锐湿疣的效果及对患者IRAK1、IRAK4、TRAF6的影响
    聂廷芬
    郑宝勇
    张彦秀
    广东医学, 2021, 42 (05) : 590 - 593
  • [48] Listeria Monocytogenes Meningoencephalitis Due to IRAK4 Deficiency
    Liu, Ding
    Chen, Ru
    Ran, Longfeng
    Zhang, Ruxu
    Chen, Han
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (07) : 1677 - 1680
  • [49] Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4
    Degorce, Sebastien L.
    Anjum, Rana
    Dillman, Keith S.
    Drew, Lisa
    Groombridge, Sam D.
    Halsall, Christopher T.
    Lenz, Eva M.
    Lindsay, Nicola A.
    Mayo, Michele F.
    Pink, Jennifer H.
    Robb, Graeme R.
    Scott, James S.
    Stokes, Stephen
    Xue, Yafeng
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (04) : 913 - 924
  • [50] Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors
    Bryan, Marian C.
    Drobnick, Joy
    Gobbi, Alberto
    Kolesnikov, Aleksandr
    Chen, Yongsheng
    Rajapaksa, Naomi
    Ndubaku, Chudi
    Feng, Jianwen
    Chang, Willy
    Francis, Ross
    Yu, Christine
    Choo, Edna F.
    DeMent, Kevin
    Ran, Yingqing
    An, Le
    Emson, Claire
    Huang, Zhiyu
    Sujatha-Bhaskar, Swathi
    Brightbill, Hans
    DiPasquale, Antonio
    Maher, Jonathan
    Wai, John
    McKenzie, Brent S.
    Lupardus, Patrick J.
    Zarrin, Ali A.
    Kiefer, James R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (13) : 6223 - 6240